BEGIN:VCALENDAR
PRODID:-//Microsoft Corporation//Outlook 11.0 MIMEDIR//EN
VERSION:2.0
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:20260806T120012-808049045@ecco.be
DTSTART:20261013T140000
DTEND:20261014T090000
DTSTAMP:20260806T100012
SUMMARY:Transforming Blood Cancer Detection Through European Innovation
DESCRIPTION: The SANGUINE Project Showcase Event:\nAdvancing the HemaChip from Research to Impact\nEvery year, around 300,000 people across the EU are diagnosed with a haematological malignancy, including leukaemia, lymphoma and multiple myeloma.\n \nYet diagnosing blood cancer remains a complex challenge. With more than 100 different types and subtypes, many diseases share overlapping clinical and laboratory features, requiring multiple tests to reach an accurate diagnosis.\n\n \nAs part of the EU Cancer Mission, the SANGUINE project has set out to change this. Over the past four years, this EU-funded initiative has worked to tackle this issue and revolutionise blood cancer detection. Its flagship innovation, the HemaChip, can screen for multiple blood cancers simultaneously through a fast, minimally invasive and cost-effective test.\n \nJoin us in Brussels on 13–14 October to highlight the groundbreaking achievements of the SANGUINE project, explore the science behind the HemaChip, share lessons learned, and discuss next steps for scaling up this promising innovation to benefit patients across Europe and beyond. Registrations are now open.
LOCATION: The Hoxton, , 
TRANSP:OPAQUE
END:VEVENT
END:VCALENDAR